Maria Dall'Era

Nov 9, 2024 | lupus.bmj.com | Maria Dall'Era |Kenneth C. Kalunian |Neil Solomons

DiscussionThis analysis used propensity score methodology to compare early safety and efficacy outcomes associated with the voclosporin-based triple immunosuppressive regimen used in the AURA-LV and AURORA 1 studies with the high-dose GC-based dual immunosuppressive therapy regimens used in ALMS.

May 22, 2024 | lupus.bmj.com | Anca D. Askanase |Richard A. Furie |Maria Dall'Era |Andrew Bomback

Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.